ClinicalTrials.Veeva

Menu

The Safety and Efficacy of Long-term Treatment of PINS Stimulator System for Tourette Syndrome

B

Beijing Pins Medical

Status and phase

Unknown
Early Phase 1

Conditions

Tourette Syndrome

Treatments

Device: deep brain stimulation (DBS)

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT02253498
PINS-009

Details and patient eligibility

About

The purpose of this clinical study is to verify the long term effectiveness and safety of a bilateral deep brain stimulation (DBS) produced by Beijing PINS Medical Co., Ltd. as a treatment option for patients with cognitive, behavioral, and functional disability of Tourette Syndrome.

Enrollment

20 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Subject is aged 18 or older
  2. Patient Group with Tourette's syndrome, Diagnosis of Tourette Syndrome by DSM-IV

Exclusion criteria

  1. Major Depressive Episode within the previous 6 months
  2. Schizophrenia or other psychotic disorder.Participate in other clinical trial;
  3. Has a life expectancy of < 1 year.
  4. The investigator and/or enrollment review committee, would preclude participation in the study.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

20 participants in 2 patient groups

Deep Brain Stimulation
Experimental group
Description:
Deep Brain Stimulation is on
Treatment:
Device: deep brain stimulation (DBS)
Sham Stimulation
Sham Comparator group
Description:
placebo
Treatment:
Device: deep brain stimulation (DBS)

Trial contacts and locations

0

Loading...

Central trial contact

Jia Fumin, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems